These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27321730)

  • 1. Corrigendum to "A novel and validated prognostic index in hepatocellular carcinoma: The Inflammation Based Index (IBI)".
    Pinato DJ; Stebbing J; Ishizuka M; Khan SA; Wasan HS; North BV; Kubota K; Sharma R
    J Hepatol; 2016 Jun; ():. PubMed ID: 27321730
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study.
    Pinato DJ; Karamanakos G; Arizumi T; Adjogatse D; Kim YW; Stebbing J; Kudo M; Jang JW; Sharma R
    Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1270-81. PubMed ID: 25327965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI).
    Pinato DJ; Stebbing J; Ishizuka M; Khan SA; Wasan HS; North BV; Kubota K; Sharma R
    J Hepatol; 2012 Nov; 57(5):1013-20. PubMed ID: 22732513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Inflammation-Immunity-Nutrition Score and Inflammatory Burden Index for Hepatocellular Carcinoma Patients After Hepatectomy.
    Song R; Ni H; Huang J; Yang C; Qin S; Wei H; Luo J; Huang Y; Xiang B
    J Inflamm Res; 2022; 15():6463-6479. PubMed ID: 36467989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non-small cell lung cancer.
    Xie H; Ruan G; Wei L; Deng L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Yang M; Song C; Zhang X; Shi H
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):869-878. PubMed ID: 36852672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory burden as a prognostic biomarker for cancer.
    Xie H; Ruan G; Ge Y; Zhang Q; Zhang H; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Shi H
    Clin Nutr; 2022 Jun; 41(6):1236-1243. PubMed ID: 35504166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma.
    Chan SL; Chan AW; Chan AK; Jian P; Mo F; Chan CM; Mok K; Liu C; Chong CC; Chan AT; Mok T; Yeo W
    Liver Int; 2017 Feb; 37(2):280-289. PubMed ID: 27501075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy.
    Gkika E; Bettinger D; Krafft L; Schultheiss M; Neeff HP; Maruschke L; Schulenburg M; Adebahr S; Kirste S; Nestle U; Thimme R; Grosu AL; Brunner TB
    Strahlenther Onkol; 2018 May; 194(5):403-413. PubMed ID: 29322205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive comparative analysis of prognostic value of serum systemic inflammation biomarkers for colorectal cancer: Results from a large multicenter collaboration.
    Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Song M; Zhang X; Liu X; Lin S; Yang M; Hu C; Tang M; Deng L; Hu W; Shi H
    Front Immunol; 2022; 13():1092498. PubMed ID: 36685502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can alternative liver function scores facilitate the establishment of an indication for radioablative therapy in patients with hepatocellular carcinoma?
    Ott D; Gawish A; Lux A; Heinze C; Brunner TB; Hass P
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4817-4824. PubMed ID: 36244015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study.
    Gan W; Yi Y; Fu Y; Huang J; Lu Z; Jing C; Fan J; Zhou J; Qiu S
    J Cancer; 2018; 9(1):148-156. PubMed ID: 29290780
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic Value of Inflammatory Burden Index in Advanced Gastric Cancer Patients Undergoing Multimodal Treatment.
    Pelc Z; Sędłak K; Mlak R; Leśniewska M; Mielniczek K; Rola P; Januszewski J; Zhaldak O; Rekowska A; Gęca K; Skórzewska M; Polkowski WP; Pawlik TM; Rawicz-Pruszyński K
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of the Preoperative Inflammatory Burden Index in Esophageal Cancer.
    Yin C; Okugawa Y; Kitajima T; Shimura T; Ma R; Kawamura M; Yoshiyama S; Okita Y; Ohi M; Toiyama Y
    Oncology; 2024; 102(7):556-564. PubMed ID: 38142688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
    Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
    Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article.
    Fu YP; Ni XC; Yi Y; Cai XY; He HW; Wang JX; Lu ZF; Han X; Cao Y; Zhou J; Fan J; Qiu SJ
    Medicine (Baltimore); 2016 Feb; 95(7):e2784. PubMed ID: 26886627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
    Wang C; He W; Yuan Y; Zhang Y; Li K; Zou R; Liao Y; Liu W; Yang Z; Zuo D; Qiu J; Zheng Y; Li B; Yuan Y
    Liver Int; 2020 Jan; 40(1):229-239. PubMed ID: 31652394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib.
    Diaz-Beveridge R; Bruixola G; Lorente D; Caballero J; Rodrigo E; Segura Á; Akhoundova D; Giménez A; Aparicio J
    Clin Transl Oncol; 2018 Mar; 20(3):322-329. PubMed ID: 28801777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI).
    Pinato DJ; North BV; Sharma R
    Br J Cancer; 2012 Apr; 106(8):1439-45. PubMed ID: 22433965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.
    Zhang T; Liu Z; Zhao X; Mao Z; Bai L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2246-2255. PubMed ID: 31169437
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assessment of Ecosystem Health of Baogang Tailings Groundwater Based on Microbiome Index of Biotic Integrity (M-IBI)].
    An XL; Chen TT; Zhao H; Zhang YC; Hou YW; Cai C
    Huan Jing Ke Xue; 2016 Sep; 37(9):3413-3422. PubMed ID: 29964775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.